Do analysts recommend MARK or YYAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Remark 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 AiRWA 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, MARK or YYAI?

AiRWA has higher revenue and earnings than Remark. Remark is trading at a lower price-to-earnings ratio than AiRWA, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Remark $5.81M 0.00 -$29.15M -$0.94 N/A AiRWA $44.05M 0.00 $3.49M $2.32 thousand 0.00

Is MARK or YYAI more profitable?

AiRWA has a net margin of -43.02% compared to Remark's net margin of -790.22%. Remark's return on equity of 0.00% beat AiRWA's return on equity. Company Net Margins Return on Equity Return on Assets Remark -790.22% N/A -332.21% AiRWA -43.02% -11.08% -9.96%

Does the media favor MARK or YYAI?

In the previous week, AiRWA had 3 more articles in the media than Remark. MarketBeat recorded 4 mentions for AiRWA and 1 mentions for Remark. Remark's average media sentiment score of 0.75 beat AiRWA's score of -0.32 indicating that Remark is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Remark 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AiRWA 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, MARK or MVLA?

Movella has lower revenue, but higher earnings than Remark. Movella is trading at a lower price-to-earnings ratio than Remark, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Remark $5.81M 0.00 -$29.15M -$0.94 N/A Movella -$559K -0.04 -$220K -$0.62 N/A

Is MARK or MVLA more profitable?

Movella has a net margin of 0.00% compared to Remark's net margin of -790.22%. Company Net Margins Return on Equity Return on Assets Remark -790.22% N/A -332.21% Movella N/A N/A N/A

Is PRST or MARK more profitable?

Presto Automation has a net margin of 0.00% compared to Remark's net margin of -790.22%. Company Net Margins Return on Equity Return on Assets Presto Automation N/A N/A N/A Remark -790.22% N/A -332.21%

Is MARK or KLDO more profitable?

Kaleido Biosciences has a net margin of 0.00% compared to Remark's net margin of -790.22%. Company Net Margins Return on Equity Return on Assets Remark -790.22% N/A -332.21% Kaleido Biosciences N/A N/A N/A

Which has better earnings & valuation, MARK or KBNT?

Kubient has lower revenue, but higher earnings than Remark. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Remark $5.81M 0.00 -$29.15M -$0.94 N/A Kubient $1.17M 0.00 -$13.62M N/A N/A

Is MARK or KBNT more profitable?

Kubient has a net margin of 0.00% compared to Remark's net margin of -790.22%. Company Net Margins Return on Equity Return on Assets Remark -790.22% N/A -332.21% Kubient N/A N/A N/A

Remark (MARK) Competitors

$0.0003 0.00 (0.00%)

As of 03:59 PM Eastern

Compare

MARK vs. YYAI, MVLA, PRST, KLDO, and KBNT

Should you buy Remark stock or one of its competitors? Remark's main competitors and comparable companies include AiRWA (YYAI), Movella (MVLA), Presto Automation (PRST), Kaleido Biosciences (KLDO), and Kubient (KBNT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "software" industry.

How does Remark compare to AiRWA?

Remark (NASDAQ:MARK) and AiRWA (NASDAQ:YYAI) are both small-cap technology companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

Remark has a beta of 1.48, suggesting that its share price is 48% more volatile than the broader market. Comparatively, AiRWA has a beta of -1.68, suggesting that its share price is 268% less volatile than the broader market.

AiRWA has a net margin of -43.02% compared to Remark's net margin of -790.22%. Remark's return on equity of 0.00% beat AiRWA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Remark	-790.22%	N/A	-332.21%
AiRWA	-43.02%	-11.08%	-9.96%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Remark	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
AiRWA	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

8.5% of Remark shares are held by institutional investors. Comparatively, 4.0% of AiRWA shares are held by institutional investors. 5.8% of Remark shares are held by insiders. Comparatively, 13.8% of AiRWA shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, AiRWA had 3 more articles in the media than Remark. MarketBeat recorded 4 mentions for AiRWA and 1 mentions for Remark. Remark's average media sentiment score of 0.75 beat AiRWA's score of -0.32 indicating that Remark is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Remark	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AiRWA	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

AiRWA has higher revenue and earnings than Remark. Remark is trading at a lower price-to-earnings ratio than AiRWA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Remark	$5.81M	0.00	-$29.15M	-$0.94	N/A
AiRWA	$44.05M	0.00	$3.49M	$2.32 thousand	0.00

Summary

AiRWA beats Remark on 9 of the 14 factors compared between the two stocks.

How does Remark compare to Movella?

Remark (NASDAQ:MARK) and Movella (NASDAQ:MVLA) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

In the previous week, Remark had 1 more articles in the media than Movella. MarketBeat recorded 1 mentions for Remark and 0 mentions for Movella. Remark's average media sentiment score of 0.75 beat Movella's score of 0.00 indicating that Remark is being referred to more favorably in the media.

Company	Overall Sentiment
Remark	Positive
Movella	Neutral

Movella has a net margin of 0.00% compared to Remark's net margin of -790.22%.

Company	Net Margins	Return on Equity	Return on Assets
Remark	-790.22%	N/A	-332.21%
Movella	N/A	N/A	N/A

Remark has a beta of 1.48, meaning that its share price is 48% more volatile than the broader market. Comparatively, Movella has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market.

8.5% of Remark shares are owned by institutional investors. Comparatively, 40.9% of Movella shares are owned by institutional investors. 5.8% of Remark shares are owned by insiders. Comparatively, 20.0% of Movella shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Movella has lower revenue, but higher earnings than Remark. Movella is trading at a lower price-to-earnings ratio than Remark, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Remark	$5.81M	0.00	-$29.15M	-$0.94	N/A
Movella	-$559K	-0.04	-$220K	-$0.62	N/A

Summary

Remark and Movella tied by winning 6 of the 12 factors compared between the two stocks.

How does Remark compare to Presto Automation?

Presto Automation (NASDAQ:PRST) and Remark (NASDAQ:MARK) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

Presto Automation has a net margin of 0.00% compared to Remark's net margin of -790.22%.

Company	Net Margins	Return on Equity	Return on Assets
Presto Automation	N/A	N/A	N/A
Remark	-790.22%	N/A	-332.21%

20.9% of Presto Automation shares are owned by institutional investors. Comparatively, 8.5% of Remark shares are owned by institutional investors. 10.0% of Presto Automation shares are owned by insiders. Comparatively, 5.8% of Remark shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Presto Automation has a beta of -3.45, meaning that its share price is 445% less volatile than the broader market. Comparatively, Remark has a beta of 1.48, meaning that its share price is 48% more volatile than the broader market.

Remark has lower revenue, but higher earnings than Presto Automation. Remark is trading at a lower price-to-earnings ratio than Presto Automation, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Presto Automation	$19.05M	0.00	-$34.48M	-$1.23	N/A
Remark	$5.81M	0.00	-$29.15M	-$0.94	N/A

In the previous week, Remark had 1 more articles in the media than Presto Automation. MarketBeat recorded 1 mentions for Remark and 0 mentions for Presto Automation. Remark's average media sentiment score of 0.75 beat Presto Automation's score of 0.00 indicating that Remark is being referred to more favorably in the news media.

Company	Overall Sentiment
Presto Automation	Neutral
Remark	Positive

Summary

Presto Automation beats Remark on 6 of the 11 factors compared between the two stocks.

How does Remark compare to Kaleido Biosciences?

Remark (NASDAQ:MARK) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap technology companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

In the previous week, Remark had 1 more articles in the media than Kaleido Biosciences. MarketBeat recorded 1 mentions for Remark and 0 mentions for Kaleido Biosciences. Remark's average media sentiment score of 0.75 beat Kaleido Biosciences' score of 0.00 indicating that Remark is being referred to more favorably in the media.

Company	Overall Sentiment
Remark	Positive
Kaleido Biosciences	Neutral

Remark has higher revenue and earnings than Kaleido Biosciences. Remark is trading at a lower price-to-earnings ratio than Kaleido Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Remark	$5.81M	0.00	-$29.15M	-$0.94	N/A
Kaleido Biosciences	$1.10M	0.00	-$95.48M	-$2.24	N/A

Remark has a beta of 1.48, meaning that its share price is 48% more volatile than the broader market. Comparatively, Kaleido Biosciences has a beta of -0.06, meaning that its share price is 106% less volatile than the broader market.

Kaleido Biosciences has a net margin of 0.00% compared to Remark's net margin of -790.22%.

Company	Net Margins	Return on Equity	Return on Assets
Remark	-790.22%	N/A	-332.21%
Kaleido Biosciences	N/A	N/A	N/A

8.5% of Remark shares are owned by institutional investors. Comparatively, 81.6% of Kaleido Biosciences shares are owned by institutional investors. 5.8% of Remark shares are owned by insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Remark and Kaleido Biosciences tied by winning 6 of the 12 factors compared between the two stocks.

How does Remark compare to Kubient?

Remark (NASDAQ:MARK) and Kubient (NASDAQ:KBNT) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

Kubient has a net margin of 0.00% compared to Remark's net margin of -790.22%.

Company	Net Margins	Return on Equity	Return on Assets
Remark	-790.22%	N/A	-332.21%
Kubient	N/A	N/A	N/A

8.5% of Remark shares are held by institutional investors. Comparatively, 13.9% of Kubient shares are held by institutional investors. 5.8% of Remark shares are held by company insiders. Comparatively, 22.3% of Kubient shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Remark had 1 more articles in the media than Kubient. MarketBeat recorded 1 mentions for Remark and 0 mentions for Kubient. Remark's average media sentiment score of 0.75 beat Kubient's score of 0.00 indicating that Remark is being referred to more favorably in the media.

Company	Overall Sentiment
Remark	Positive
Kubient	Neutral

Kubient has lower revenue, but higher earnings than Remark.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Remark	$5.81M	0.00	-$29.15M	-$0.94	N/A
Kubient	$1.17M	0.00	-$13.62M	N/A	N/A

Remark has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market. Comparatively, Kubient has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

Summary

Remark beats Kubient on 6 of the 11 factors compared between the two stocks.

Get Remark News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MARK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MARK vs. The Competition

Export

Metric	Remark	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$20K	$15.90B	$30.86B	$13.10B
Dividend Yield	N/A	3.41%	2.75%	12.57%
P/E Ratio	0.00	142.47	79.12	25.75
Price / Sales	0.00	1,284.67	586.60	97.61
Price / Cash	N/A	47.54	49.70	52.76
Price / Book	0.00	8.85	7.98	6.34
Net Income	-$29.15M	$434.54M	$702.99M	$360.00M
7 Day Performance	N/A	0.35%	1.21%	-0.10%
1 Month Performance	N/A	-2.60%	-1.32%	-3.41%
1 Year Performance	N/A	-1.27%	178.25%	5.46%

Remark Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MARK Remark	N/A	$0.00 flat	N/A	-94.0%	$20K	$5.81M	N/A	70
YYAI AiRWA	1.3305 of 5 stars	$0.71 -2.3%	N/A	-100.0%	$40K	$12.82M	0.00	8	Earnings Report
MVLA Movella	N/A	$0.00 flat	N/A	-90.0%	$10K	-$559K	N/A	3
PRST Presto Automation	N/A	N/A	N/A	N/A	$10K	$19.05M	N/A	4
KLDO Kaleido Biosciences	N/A	$0.00 flat	N/A	N/A	$4K	$1.10M	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MARK) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Remark (MARK) Competitors